ProQR Therapeutics is a high-potential, early-stage RNA editing platform company, but remains pre-proof-of-mechanism in ...
Detailed price information for Barry Callebaut Ag (BYCBF) from The Globe and Mail including charting and trades.
Buy Allison Transmission (ALSN) now: dominant market share, strong free cash flow, defense & electrification catalysts, and ...
Shares of cybersecurity platform provider CrowdStrike (NASDAQ:CRWD) fell 7.4% in the afternoon session after Anthropic ...
Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 monthsTop-line data expected year-end ...
Procter & Gamble (NYSE: PG) is trading at $143.11 on April 16, 2026, down 0.19% on the session with an after-hours indication of $143.40, a market capitalization of $333.22 billion, a forward P/E of ...
Phase 3 trial evaluated two subcutaneous BRIUMVI dosing regimens; administration every 2 months or every 3 months Top-line data expected year-end 2026/ first quarter 2027 NEW YORK, April 15, 2026 (GLO ...
In this piece, we will discuss the 10 Stocks Under $5 That Will Explode. Recent market analyses justify a selective approach ...
A closer look at the top group of high school prospects in the 2026 MLB Draft that the Atlanta Braves might select.
Stocktwits on MSN
PLTR stock loses over 12% in three days — is the defense boost over?
Palantir and other defense stocks have given up much of their war-driven gains, as the initial rally fueled by the conflict begins to fade. ・Palantir’s forward P/E is now the lowest in five months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results